4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine

C80H94F3N33O3S — CID 157484791

IUPAC4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine
SMILESCc1c(Nc2ncnc(N3CCN(c4ncc(Cc5ccc(F)cc5)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.Cc1c(Nc2ncnc(N3CCN(c4ncc(Cc5ccccc5F)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.Cc1c(Nc2ncnc(N3CCN(c4ncc(Sc5ccc(F)cc5)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1
InChIInChI=1S/2C27H32FN11O.C26H30FN11OS/c1-19-24(16-34-39(19)17-23-15-29-6-11-40-23)35-25-32-18-33-27(36-25)38-9-7-37(8-10-38)26-30-13-21(14-31-26)12-20-2-4-22(28)5-3-20;1-19-24(16-34-39(19)17-22-15-29-6-11-40-22)35-25-32-18-33-27(36-25)38-9-7-37(8-10-38)26-30-13-20(14-31-26)12-21-4-2-3-5-23(21)28;1-18-23(15-33-38(18)16-20-12-28-6-11-39-20)34-24-31-17-32-26(35-24)37-9-7-36(8-10-37)25-29-13-22(14-30-25)40-21-4-2-19(27)3-5-21/h2-5,13-14,16,18,23,29H,6-12,15,17H2,1H3,(H,32,33,35,36);2-5,13-14,16,18,22,29H,6-12,15,17H2,1H3,(H,32,33,35,36);2-5,13-15,17,20,28H,6-12,16H2,1H3,(H,31,32,34,35)/t23-;22-;20-/m000/s1
InChIKeyBWOUEQWYACHOBS-BSNZPALUSA-N
MW1654.92 g/mol
LogP6.43
Rot. Bonds24

About 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine

4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine (PubChem CID 157484791) has the molecular formula C80H94F3N33O3S and a molecular weight of 1654.92 g/mol. Its IUPAC name is 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine.

Molecular Properties

Compound Name4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine
PubChem CID157484791
Molecular FormulaC80H94F3N33O3S
Molecular Weight1654.92 g/mol
Exact Mass1653.79
IUPAC Name4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine
SMILESCc1c(Nc2ncnc(N3CCN(c4ncc(Cc5ccc(F)cc5)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.Cc1c(Nc2ncnc(N3CCN(c4ncc(Cc5ccccc5F)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.Cc1c(Nc2ncnc(N3CCN(c4ncc(Sc5ccc(F)cc5)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1
InChIInChI=1S/2C27H32FN11O.C26H30FN11OS/c1-19-24(16-34-39(19)17-23-15-29-6-11-40-23)35-25-32-18-33-27(36-25)38-9-7-37(8-10-38)26-30-13-21(14-31-26)12-20-2-4-22(28)5-3-20;1-19-24(16-34-39(19)17-22-15-29-6-11-40-22)35-25-32-18-33-27(36-25)38-9-7-37(8-10-38)26-30-13-20(14-31-26)12-21-4-2-3-5-23(21)28;1-18-23(15-33-38(18)16-20-12-28-6-11-39-20)34-24-31-17-32-26(35-24)37-9-7-36(8-10-37)25-29-13-22(14-30-25)40-21-4-2-19(27)3-5-21/h2-5,13-14,16,18,23,29H,6-12,15,17H2,1H3,(H,32,33,35,36);2-5,13-14,16,18,22,29H,6-12,15,17H2,1H3,(H,32,33,35,36);2-5,13-15,17,20,28H,6-12,16H2,1H3,(H,31,32,34,35)/t23-;22-;20-/m000/s1
InChIKeyBWOUEQWYACHOBS-BSNZPALUSA-N
XLogP6.43
TPSA366.12 Ų
H-Bond Donors6
H-Bond Acceptors37
Rotatable Bonds24
Heavy Atoms120
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001654.92
LogP ≤ 56.43
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1037

Analyze 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine?
The IUPAC name of 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine (CID 157484791) is 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine.
What is the SMILES notation for 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine?
The canonical SMILES for 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine is Cc1c(Nc2ncnc(N3CCN(c4ncc(Cc5ccc(F)cc5)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.Cc1c(Nc2ncnc(N3CCN(c4ncc(Cc5ccccc5F)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.Cc1c(Nc2ncnc(N3CCN(c4ncc(Sc5ccc(F)cc5)cn4)CC3)n2)cnn1C[C@@H]1CNCCO1.
What is the InChIKey of 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine?
The InChIKey is BWOUEQWYACHOBS-BSNZPALUSA-N. The full InChI is InChI=1S/2C27H32FN11O.C26H30FN11OS/c1-19-24(16-34-39(19)17-23-15-29-6-11-40-23)35-25-32-18-33-27(36-25)38-9-7-37(8-10-38)26-30-13-21(14-31-26)12-20-2-4-22(28)5-3-20;1-19-24(16-34-39(19)17-22-15-29-6-11-40-22)35-25-32-18-33-27(36-25)38-9-7-37(8-10-38)26-30-13-20(14-31-26)12-21-4-2-3-5-23(21)28;1-18-23(15-33-38(18)16-20-12-28-6-11-39-20)34-24-31-17-32-26(35-24)37-9-7-36(8-10-37)25-29-13-22(14-30-25)40-21-4-2-19(27)3-5-21/h2-5,13-14,16,18,23,29H,6-12,15,17H2,1H3,(H,32,33,35,36);2-5,13-14,16,18,22,29H,6-12,15,17H2,1H3,(H,32,33,35,36);2-5,13-15,17,20,28H,6-12,16H2,1H3,(H,31,32,34,35)/t23-;22-;20-/m000/s1.
What are the key properties of 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine?
4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine has a molecular weight of 1654.92 g/mol, XLogP of 6.43, 24 rotatable bonds, 6 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[5-[(2-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine;4-[4-[5-(4-fluorophenyl)sulfanylpyrimidin-2-yl]piperazin-1-yl]-N-[5-methyl-1-[[(2S)-morpholin-2-yl]methyl]pyrazol-4-yl]-1,3,5-triazin-2-amine is sourced from PubChem (CID 157484791), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).